Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

J.W. Jacobeit, L.J.G. Gooren, H.M. Schulte

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)795-798
JournalEuropean Journal of Endocrinology
Volume161
Issue number5
DOIs
Publication statusPublished - 2009

Cite this